The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
insulin glargine · Crystal
2 marketed package NDCs · 1 active manufacturer
Most dispensed: 100 [iU]/mL · Injection, Solution · #5 syringes/carton / 3 ml in 1 syringe · 100 [iU]/mL · Injection, Solution · #1 vial, glass/carton / 10 ml in 1 vial, glass · 300 U/mL · Injection, Solution · #2 syringes/carton / 3 ml in 1 syringe · 300 U/mL · Injection, Solution · #3 syringes/carton / 1.5 ml in 1 syringe
What changed in the last 90 days
Every detected change for insulin glargine, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- Insulin glargine U-300Aug 19, 2026Price downNADAC $27.05941 → $27.02158 per unit (-0.14%)
- Insulin glargine U-300 MaxAug 19, 2026Price downNADAC $27.02739 → $27.01429 per unit (-0.05%)
- LantusAug 19, 2026Price downNADAC $6.15615 → $6.14925 per unit (-0.11%)
- Lantus SolostarAug 19, 2026Price downNADAC $6.16587 → $6.16474 per unit (-0.02%)
- TOUJEO MaxAug 19, 2026Price downNADAC $91.25793 → $91.23595 per unit (-0.02%)
- ToujeoAug 19, 2026Price downNADAC $91.32167 → $91.30492 per unit (-0.02%)
- BASAGLAR KwikPenAug 19, 2026Price upNADAC $20.92664 → $20.92879 per unit (+0.01%)
- Insulin glargine U-300Jul 22, 2026Price upNADAC $27.01155 → $27.05941 per unit (+0.18%)
- Insulin glargine U-300 MaxJul 22, 2026Price upNADAC $26.98949 → $27.02739 per unit (+0.14%)
- ToujeoJul 22, 2026Price downNADAC $91.3337 → $91.32167 per unit (-0.01%)
Same drug class
Other molecules FDA puts in Insulin Analog, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- attention deficit mild drops· 1 maker
- attention deficit severe drops· 1 maker
- dna insulin drops· 1 maker
- insulin aspart injection· 1 maker
- insulin aspart-fsan· 1 maker
- insulin aspart-xjhz· 1 maker
- insulin degludec and liraglutide· 1 maker
- insulin glargine and lixisenatide· 1 maker
- insulin glargine-aldy· 1 maker
- insulin glulisine· 1 maker
- pancreas db liquescence· 1 maker
- insulin· 2 makers
Common questions
- Is Insulin glargine in shortage right now?
- No. FDA does not currently list Insulin glargine in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Insulin glargine?
- 8 companies have marketed Insulin glargine in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Insulin glargine cost?
- The typical pharmacy pays about $27.01 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.